Sign in
4

Changes in Ownership

SpyGlass Pharma, Inc. Filed Acc 0001744662-26-000004

Options or other derivatives

  • Director acquired 13,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
O'Farrell Elizabeth G. Director 2026-02-05 Grant or award · Stock Option (right to buy) +13,700 13,700 D
Loading xslF345X05/form4-02092026_090256.xml…